Trial Profile
Clinical Trials Insight: 700035119
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 09 Jul 2008
Price :
$35
*
At a glance
- Drugs EX 1314 (Primary)
- Indications Diabetic gastroparesis; Gastrointestinal disorders
- Focus Adverse reactions
- Sponsors Elixir Pharmaceuticals
- 09 Jul 2008 New trial record.